A Phase 3, Open-label Study to Determine the Long-term Safety and Efficacy of Vedolizumab (MLN0002) in Subjects With Ulcerative Colitis and Crohn's Disease
收藏DataCite Commons2026-01-27 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/studies/00006457/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
The purpose of this multicenter, open-label study is to collect data on the occurrence of important clinical safety events resulting from chronic vedolizumab (MLN0002) administration.
提供机构：
Vivli
创建时间：
2020-11-03
